Food and Drug Administration. Zithromax (azithromycin): FDA Statement on risk of cardiovascular death. USA; 2012. [citado em 21 Mai 2012]. Disponível em: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm304503.htm.

Ray WA, Murray KT, Hall K, Arbogast PG, Stein CM. Azithromycinthe Risk of Cardiovascular Death. N Engl J Med. 2012 [citado em 21 Mai 2012]; 366:1881-1890. Disponível em:

http://www.nejm.org/doi/full/10.1056/NEJMoa1003833.